SYAHRANI, RESDA A., MELVA LOUISA, and SEPTELIA I. WANANDI. 2019. “SENSITIVITY OF BREAST CANCER STEM CELLS (CD24-/CD44+) TO DOXORUBICIN IS ASSOCIATED WITH OXIDATIVE STRESS STATUS”. International Journal of Applied Pharmaceutics 11 (6), 91-96. https://doi.org/10.22159/ijap.2019.v11s6.33555.